MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 58 filers reported holding MIRATI THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,671,000 | +165.2% | 57,000 | +67.6% | 0.23% | +160.7% |
| Q4 2014 | $630,000 | +5.9% | 34,000 | 0.0% | 0.09% | -2.2% |
| Q3 2014 | $595,000 | -12.5% | 34,000 | 0.0% | 0.09% | -13.3% |
| Q2 2014 | $680,000 | +4.9% | 34,000 | 0.0% | 0.10% | +1.9% |
| Q1 2014 | $648,000 | +14.7% | 34,000 | 0.0% | 0.10% | +13.2% |
| Q4 2013 | $565,000 | -45.1% | 34,000 | -50.0% | 0.09% | -53.6% |
| Q3 2013 | $1,030,000 | – | 68,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |